https://pubmed.ncbi.nlm.nih.gov/15269313/
Cetuximab has clinically significant activity when given alone or in combination with irinotecan in patients with irinotecan-refractory colorectal cancer.
cetuximabmonotherapyplusirinotecanrefractory
https://www.mdpi.com/2077-0383/10/5/1098
We investigated the long-term visual and anatomical outcomes of aflibercept monotherapy for exudative age-related macular degeneration (AMD) with good baseline...
fiveyearoutcomeafliberceptmonotherapy
https://pubmed.ncbi.nlm.nih.gov/25764683/
Pegylated-interferon(PEG-IFN)/interferon monotherapy for patients with chronic hepatitis C has been used for two clinical aims; one is for the elimination of...
pegifnmonotherapy
https://www.biospace.com/alkermes-advances-alks-4230-into-monotherapy-expansion-phase-of-artistry-1-in-patients-with-renal-cell-carcinoma-or-melanoma
Alkermes plc announced the initiation of the monotherapy expansion stage of its ARTISTRY-1 clinical trial to evaluate the efficacy, safety and tolerability of...
alkermesadvancesalksmonotherapyexpansion